Multilayer-omics analyses of human cancers: Exploration of biomarkers and drug targets based on the activities of the International Human Epigenome Consortium

Frontiers in Genetics

Volumn 5, Issue FEB, 2014, Pages

  Kanai, Yae ^a,b   Arai, Eri ^a,b  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

DNA methylation; Epigenetics; Epigenome; International Human Epigenome Consortium (IHEC); Multilayer integrated disease omics analyses

Indexed keywords

BIOLOGICAL MARKER; DNA; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; MESSENGER RNA; MICRORNA; PROTEOME; RNA POLYMERASE II; TRANSCRIPTOME;

CARCINOGENESIS; CELL LINEAGE; CHRONIC INFLAMMATION; CPG ISLAND; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; GENETIC HETEROGENEITY; GENOME; HISTONE MODIFICATION; HUMAN; METABOLIC DISORDER; METABOLOME; MICROORGANISM; NEOPLASM; SHORT SURVEY; SMOKING; TRANSCRIPTION REGULATION; VIRUS INFECTION;

EID: 84897704591     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2014.00024     Document Type: Short Survey

References (32)

1. Arai, E., Chiku, S., Mori, T., Gotoh, M., Nakagawa, T., Fujimoto, H., et al. (2012). Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas. Carcinogenesis 33, 1487-1493. doi: 10.1093/carcin/bgs177.
2. Arai, E., and Kanai, Y. (2010). DNA methylation profiles in precancerous tissue and cancers: carcinogenetic risk estimation and prognostication based on DNA methylation status. Epigenomics 2, 467-481. doi: 10.2217/epi.10.16.
3. Arai, E., Kanai, Y., Ushijima, S., Fujimoto, H., Mukai, K., and Hirohashi, S. (2006). Regional DNA hypermethylation and DNA methyltransferase (DNMT) 1 protein overexpression in both renal tumors and corresponding nontumorous renal tissues. Int. J. Cancer 119, 288-296. doi:10.1002/ijc.21807.
4. Arai, E., Ushijima, S., Fujimoto, H., Hosoda, F., Shibata, T., Kondo, T., et al. (2009a). Genome-wide DNA methylation profiles in both precancerous conditions and clear cell renal cell carcinomas are correlated with malignant potential and patient outcome. Carcinogenesis 30, 214-221. doi: 10.1093/carcin/bgn268.
5. Arai, E., Ushijima, S., Gotoh, M., Ojima, H., Kosuge, T., Hosoda, F., et al. (2009b). Genome-wide DNA methylation profiles in liver tissue at the precancerous stage and in hepatocellular carcinoma. Int. J. Cancer 125, 2854-2862. doi: 10.1002/ijc.24708.
6. Bae, J. B. (2013). Perspectives of international human epigenome consortium. Genomics Inform. 11, 7-14. doi: 10.5808/GI.2013.11.1.7.
7. Djebali, S., Davis, C. A., Merkel, A., Dobin, A., Lassmann, T., Mortazavi, A., et al. (2012). Landscape of transcription in human cells. Nature 489, 101-108. doi: 10.1038/nature11233.
8. Etoh, T., Kanai, Y., Ushijima, S., Nakagawa, T., Nakanishi, Y., Sasako, M., et al. (2004). Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am. J. Pathol. 164, 689-699. doi: 10.1016/S0002-9440(10)63156-2.
9. Fabbri, M., Garzon, R., Cimmino, A., Liu, Z., Zanesi, N., Callegari, E., et al. (2007). MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl. Acad. Sci. U.S.A. 104, 15805-15810. doi:10.1073/pnas.0707628104.
10. Gomes, A. Q., Nolasco, S., and Soares, H. (2013). Non-coding RNAs: multi-tasking molecules in the cell. Int. J. Mol. Sci. 14, 16010-16039. doi: 10.3390/ijms140816010.
11. Gotoh, M., Arai, E., Wakai-Ushijima, S., Hiraoka, N., Kosuge, T., Hosoda, F., et al. (2011). Diagnosis and prognostication of ductal adenocarcinomas of the pancreas based on genome-wide DNA methylation profiling by bacterial artificial chromosome array-based methylated CpG island amplification. J. Biomed. Biotechnol. 2011, 780836. doi: 10.1155/2011/780836.
12. He, L., and Hannon, G. J. (2004). MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5, 522-531. doi: 10.1038/nrg1379.
13. Huang, J., Wang, Y., Guo, Y., and Sun, S. (2010). Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology 52, 60-70. doi: 10.1002/hep.23660.
14. Jinek, M., and Doudna, J. A. (2009). A three-dimensional view of the molecular machinery of RNA interference. Nature 457, 405-412. doi: 10.1038/nature07755.
15. Kanai, Y. (2008). Alterations of DNA methylation and clinicopathological diversity of human cancers. Pathol. Int. 58, 544-558. doi: 10.1111/j.1440-1827.2008.02270.x.
16. Kanai, Y. (2010). Genome-wide DNA methylation profiles in precancerous conditions and cancers. Cancer Sci. 101, 36-45. doi: 10.1111/j.1349-7006.2009.01383.x.
17. Kanai, Y., and Hirohashi, S. (2007). Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. Carcinogenesis 28, 2434-2442. doi: 10.1093/carcin/bgm206.
18. Kanai, Y., Ushijima, S., Tsuda, H., Sakamoto, M., Sugimura, T., and Hirohashi, S. (1996). Aberrant DNA methylation on chromosome 16 is an early event in hepatocarcinogenesis. Jpn. J. Cancer Res. 87, 1210-1217. doi: 10.1111/j.1349-7006.1996.tb03135.x.
19. Kim, D. H., Saetrom, P., Snøve, O. Jr., and Rossi, J. J. (2008). MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 105, 16230-16235. doi: 10.1073/pnas.0808830105.
20. Lister, R., O'Malley, R. C., Tonti-Filippini, J., Gregory, B. D., Berry, C. C., Millar, A. H., et al. (2008). Highly integrated single-base resolution maps of the epigenome in Arabidopsis. Cell 133, 523-536. doi: 10.1016/j.cell.2008.03.029.
21. Lujambio, A., Ropero, S., Ballestar, E., Fraga, M. F., Cerrato, C., Setién, F., et al. (2007). Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res. 67, 1424-1429. doi: 10.1158/0008-5472.CAN-06-4218.
22. Miura, F., Enomoto, Y., Dairiki, R., and Ito, T. (2012). Amplification-free whole-genome bisulfite sequencing by post-bisulfite adaptor tagging. Nucleic Acids Res. 40, e136. doi: 10.1093/nar/gks454.
23. Nakagawa, T., Kanai, Y., Ushijima, S., Kitamura, T., Kakizoe, T., and Hirohashi, S. (2005). DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis. J. Urol. 173, 1767-1771. doi: 10.1097/01.ju.0000154632.11824.4d.
24. Nishiyama, N., Arai, E., Chihara, Y., Fujimoto, H., Hosoda, F., Shibata, T., et al. (2010). Genome-wide DNA methylation profiles in urothelial carcinomas and urothelia at the precancerous stage. Cancer Sci. 101, 231-240. doi: 10.1111/j.1349-7006.2009.01330.x.
25. Peng, D. F., Kanai, Y., Sawada, M., Ushijima, S., Hiraoka, N., Kitazawa, S., et al. (2006). DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreas. Carcinogenesis 27, 1160-1168. doi: 10.1093/carcin/bgi361.
26. Saito, Y., Kanai, Y., Sakamoto, M., Saito, H., Ishii, H., and Hirohashi, S. (2002). Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 99, 10060-10065. doi: 10.1073/pnas.152121799.
27. Saito, Y., Liang, G., Egger, G., Friedman, J. M., Chuang, J. C., and Coetzee. G. A., et al. (2006). Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9, 435-443. doi: 10.1016/j.ccr.2006.04.020.
28. Saito, Y., Saito, H., Liang, G., and Friedman, J. M. (2013). Epigenetic alterations and microRNA misexpression in cancer and autoimmune diseases: a critical review. Clin. Rev. Allergy Immunol. doi: 10.1007/s12016-013-8401-z [Epub ahead of print].
29. Saito, Y., Suzuki, H., Tsugawa, H., Nakagawa, I., Matsuzaki, J., Kanai, Y., et al. (2009). Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells. Oncogene 28, 2738-2744. doi: 10.1038/onc.2009.140.
30. Sato, T., Arai, E., Kohno T., Takahashi, Y., Miyata, S., Tsuta, K., et al. (2014). Epigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: its correlation with smoking history and chronic obstructive pulmonary disease. Int. J. Cancer doi: 10.1002/ijc.28684.
31. Sato, T., Arai, E., Kohno, T., Tsuta, K., Watanabe, S., Soejima, K., et al. (2013). DNA methylation profiles at precancerous stages associated with recurrence of lung adenocarcinoma. PLoS ONE 8:e59444. doi: 10.1371/journal.pone.0059444.
32. Yoshiura, K., Kanai, Y., Ochiai, A., Shimoyama, Y., Sugimura, T., and Hirohashi, S. (1995). Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl. Acad. Sci. U.S.A. 92, 7416-7419. doi: 10.1073/pnas.92.16.7416.